Clinical Analysis of 67 Cases with Primary Esophageal Small Cell Carcinoma

ZHAO Hua-feng,ZHAO Xi-jiang,TANG Peng,MA Ming-quan,WANG Shi-jiang
DOI: https://doi.org/10.3969/j.issn.1006-8147.2007.03.024
2007-01-01
Abstract:0bjective: To investigate the dignosis,treatment and prognosis of primary esophageal small cell carcinoma (PESCC). Methods: Retrospective analysis was made on the 67 cases of pathologically testified PESCC that were collected during the period of January 1981 to November 2006.The treatment and prognosis were discussed combined with other literatures. Results: Operation,chemotherapy,radiotherapy,and combined therapy were carried out respectively on the cases according to their different conditions. After treatment,the I+Ⅱa stage、Ⅲ stage and IV stage’s median survival period were 13 months,9.5 months and 7 months respectively .With the development of the stage,the prognosis become worse and worse,and the difference was significant(P0.05). For limited stage ,among various kinds of treatment methods,operation combined chemotherapy's median survival period was 16 months ,and the pure operation's median survival period was 11 months.The operation combined chemotherapy treatment scheme was superior to pure operation for the limited stage,and the difference was significant(P0.05).For the extensive stage,the radiotherapy combined chemotherapy treatment scheme's median survival period was longest ,but various kinds of methods had no significant difference(P0.05). Conclusion: PESCC is a highly malignant disease with early extension,most of the patients die within twelve months.So this kind of patients should have dignosis early and have a suitable treatment scheme to improve the prognosis and the life quality of patients.
What problem does this paper attempt to address?